Published in J Hum Hypertens on January 01, 1999
Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovasc Disord (2009) 2.37
A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Cardiovasc J Afr (2010) 1.86
Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World J Cardiol (2012) 1.64
The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: experiences from the Isfahan healthy heart program. BMC Cardiovasc Disord (2010) 1.29
Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population - a cross sectional study. BMC Res Notes (2010) 1.22
Prevalence, awareness, treatment and control of hypertension among adults 50 years and older in Dakar, Senegal. Cardiovasc J Afr (2011) 1.01
Prevalence of hypertension in three rural communities of Ife North Local Government Area of Osun State, South West Nigeria. Int J Gen Med (2013) 0.92
Prevalence of hypertension among urban slum dwellers in Lagos, Nigeria. J Urban Health (2013) 0.91
Relationship of anthropometric indicators with blood pressure levels and the risk of hypertension in Nigerian adults. Int J Gen Med (2008) 0.90
The prevalence, awareness, and control of hypertension among workers in West Africa: a systematic review. Glob Health Action (2015) 0.84
QT Interval prolongation and dispersion: Epidemiology and clinical correlates in subjects with newly diagnosed systemic hypertension in Nigeria. J Cardiovasc Dis Res (2012) 0.83
Socio-economic status of patients with type 2 diabetes and hypertension attending the Ahmadu Bello University Teaching Hospital, Zaria, North-West Nigeria. Glob J Health Sci (2014) 0.83
The prevalence of diastolic dysfunction in adult hypertensive nigerians. Ghana Med J (2006) 0.83
Overweight and Obesity, Lipid Profile and Atherogenic Indices among Civil Servants in Abakaliki, South Eastern Nigeria. Ann Med Health Sci Res (2013) 0.80
Preventing Diabetes and Atherosclerosis in Sub-Saharan Africa: Should the Metabolic Syndrome Have a Role? Curr Cardiovasc Risk Rep (2009) 0.79
High blood pressure in a semi-urban community in south-south Nigeria: a community-based study. Afr Health Sci (2013) 0.79
Physical activity and pattern of blood pressure in postmenopausal women with hypertension in Nigeria. Ethiop J Health Sci (2014) 0.78
Prevalence of left ventricular diastolic dysfunction in newly diagnosed Nigerians with systemic hypertension: a pulsed wave Doppler echocardiographic study. Afr Health Sci (2010) 0.77
Male erectile dysfunction and microalbuminuria in adult nigerians with essential hypertension. N Am J Med Sci (2013) 0.76
The prevalence and associated factors for prehypertension and hypertension in Cambodia. Heart Asia (2013) 0.75
Prevalence of Hypertension in Akwa Ibom State, South-South Nigeria: Rural versus Urban Communities Study. Int J Hypertens (2015) 0.75
Casual blood pressure of adolescents attending public secondary schools in Maiduguri, Nigeria. Clin Hypertens (2015) 0.75
Pattern of cardiovascular admissions at Nnamdi Azikiwe University Teaching Hospital Nnewi, South East Nigeria. Pan Afr Med J (2014) 0.75
Awareness, Treatment, and Control of Hypertension in Primary Health Care and Secondary Referral Medical Outpatient Clinic Settings at Enugu, Southeast Nigeria. Int J Hypertens (2016) 0.75
Determinants of Mean Blood Pressure and Hypertension among Workers in West Africa. Int J Hypertens (2016) 0.75
Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol (1983) 2.59
Abolition of cost-sharing is pro-poor: evidence from Uganda. Health Policy Plan (2005) 2.57
Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. Br J Clin Pharmacol (1983) 1.77
Pruritus and antimalarial drugs in Africans. Lancet (1989) 1.70
Trends in coronary artery disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens (2003) 1.66
The disposition of chloroquine and its main metabolite desethylchloroquine in volunteers with and without chloroquine-induced pruritus: evidence for decreased chloroquine metabolism in volunteers with pruritus. Clin Pharmacol Ther (2000) 1.48
Parenteral sulphadoxine-pyrimethamine (Fansidar): an effective and safe but under-used method of anti-malarial treatment. Trans R Soc Trop Med Hyg (1991) 1.48
Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum. Lancet (1987) 1.46
Factors influencing the development of malignant hypertension in Nigeria. J Hum Hypertens (2000) 1.45
Malaria in Nigeria: a revisit. Ann Trop Med Parasitol (1990) 1.38
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
The disposition of amodiaquine in Zambians and Nigerians with malaria. Br J Clin Pharmacol (1990) 1.34
Characterization of chloroquine plasma protein binding in man. Br J Clin Pharmacol (1983) 1.21
Cardiovascular risk factors in middle aged Nigerians. East Afr Med J (1997) 1.12
The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. Br J Clin Pharmacol (1987) 1.11
The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria. Trans R Soc Trop Med Hyg (1981) 1.09
Cerebral malaria in non-paediatric subjects resident in southwestern Nigeria. Afr J Med Med Sci (1993) 1.08
Target organ damage and associated clinical conditions among Nigerians with treated hypertension. Cardiovasc J S Afr (2005) 1.07
A longitudinal study of seroreactivities to Plasmodium falciparum antigens in Nigerian infants during their first year of life. Acta Trop (1995) 1.06
Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br J Clin Pharmacol (1986) 1.03
Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor. Br J Clin Pharmacol (1987) 1.01
Hepatitis B virus infection: implications in chronic kidney disease, dialysis and transplantation. Afr J Med Med Sci (2006) 0.99
Chloroquine sensitivity of Plasmodium falciparum in Ibadan, Nigeria: II. Correlation of in vitro with in vivo sensitivity. Trans R Soc Trop Med Hyg (1981) 0.99
Studies on Plasmodium falciparum parasitemia and development of anemia in Nigerian infants during their first year of life. Am J Trop Med Hyg (1996) 0.97
Retinal haemorrhage in cerebral malaria. East Afr Med J (1997) 0.96
Protein energy malnutrition and cerebral malaria in Nigerian children. J Trop Pediatr (1997) 0.92
Blood pressure and educational level among factory workers in Ibadan, Nigeria. J Hum Hypertens (1991) 0.92
Traditional herbal preparations and acute renal failure in south west Nigeria. Trop Doct (1999) 0.91
Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria. Trans R Soc Trop Med Hyg (1992) 0.91
The clinical manifestations of cerebral malaria among Nigerian children with the sickle cell trait. Ann Trop Paediatr (1997) 0.87
Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria. Acta Trop (1999) 0.87
Association between electrocardiographic left ventricular hypertrophy with strain pattern and left ventricular structure and function. Cardiology (2006) 0.86
Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate. Haematologica (2005) 0.86
Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria. Trans R Soc Trop Med Hyg (1991) 0.86
The clinical presentation of malignant hypertension in Nigerians. J Hum Hypertens (1991) 0.86
Clinical efficacy of mefloquine in children suffering from chloroquine-resistant Plasmodium falciparum malaria in Nigeria. Trans R Soc Trop Med Hyg (1991) 0.85
Effect of HIV/AIDS on household welfare in Uganda rural communities: a review. East Afr Med J (2008) 0.85
Pharmacokinetics of quinine in African patients with acute falciparum malaria. Pharm World Sci (1998) 0.84
Pharmacokinetics of chloroquine in renal insufficiency. Afr J Med Med Sci (1985) 0.83
Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children. Trans R Soc Trop Med Hyg (2002) 0.83
Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children. Bull World Health Organ (1990) 0.82
Microalbuminuria and clinical correlates in black African patients with type 2 diabetes. West Afr J Med (2007) 0.82
The relationship between the response of Plasmodium falciparum malaria to mefloquine in African children and its sensitivity in vitro. Trans R Soc Trop Med Hyg (1992) 0.81
The sensitivity of Plasmodium falciparum to chloroquine and amodiaquine in Ibadan, Nigeria. Trans R Soc Trop Med Hyg (1984) 0.81
Effect of Plasmodium falciparum malaria on plasma fibrinopeptide-A (FpA) concentration. Cent Afr J Med (1995) 0.81
Focal segmental glomerulosclerosis in malignant hypertension. S Afr Med J (2002) 0.80
Influence of route of administration on the pharmaco-kinetics of chloroquine and desethylchloroquine. Bull World Health Organ (1987) 0.80
Pitfalls in the diagnosis of malaria: a-parasitaemic severe malaria. J Trop Pediatr (1992) 0.79
Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study. Ann Trop Med Parasitol (1992) 0.78
Respiratory distress adversely affects the outcome of childhood cerebral malaria. Trans R Soc Trop Med Hyg (1996) 0.78
Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients. J Pak Med Assoc (1994) 0.78
Therapeutic monitoring of chloroquine in pregnant women with malaria. West Afr J Med (2003) 0.78
Hyperparasitaemia: not a reliable indicator of severity or poor prognosis in falciparum malaria in children in endemic African countries. Ann Trop Paediatr (1992) 0.78
Hepatitis C virus (HCV) and chronic renal disease. Afr J Med Med Sci (2003) 0.77
Amlodipine as monotherapy in hypertensive Africans: clinical efficacy and safety studies. Afr J Med Med Sci (1996) 0.77
Evaluation of lacidipine (a calcium blocker) in the treatment of hypertension in black African people: a double-blind comparison with hydrochlorothiazide. Afr J Med Med Sci (1999) 0.77
Height and weight measurements of Ibadan school children. Afr J Med Med Sci (1996) 0.77
CHOLERA EPIDEMIOLOGY IN ZAMBIA FROM 2000 TO 2010: IMPLICATIONS FOR IMPROVING CHOLERA PREVENTION AND CONTROL STRATEGIES IN THE COUNTRY. East Afr Med J (2013) 0.77
Neuropsychiatric side effects of mefloquine in Africans. Trans R Soc Trop Med Hyg (1993) 0.77
Effects of aerobic exercise and drug therapy on blood pressure and antihypertensive drugs: a randomized controlled trial. Afr Health Sci (2013) 0.77
Electrocardiographic left ventricular hypertrophy with strain pattern: prevalence, mechanisms and prognostic implications. Cardiovasc J Afr (2008) 0.76
Parenteral therapy of moderately severe malaria: comparison of intramuscular artemether and intramuscular sulfadoxine-pyrimethamine. Trans R Soc Trop Med Hyg (1994) 0.76
Malaria and the problem of drug resistant Plasmodium falciparum. Afr J Med Med Sci (1993) 0.75
Ethical and legal issues in renal transplantation in Nigeria. Saudi J Kidney Dis Transpl (2016) 0.75
Short-term course of renal function in accelerated hypertension. Afr J Med Med Sci (1993) 0.75
Peripheral neuropathy in Nigerian subjects with chronic renal failure. Niger J Med (2003) 0.75
Parodoxical rise in urinary albumin levels after treatment of essential hypertension. S Afr Med J (1997) 0.75
Biochemical changes during moduretic treatment of hypertension in African patients. Kobe J Med Sci (1995) 0.75
Open trial of doxazosin in hypertensive Africans: dose finding, efficacy and safety studies. Afr J Med Med Sci (1996) 0.75
Kidney histology and clinical correlates in malignant hypertension. East Afr Med J (1993) 0.75
Biochemical changes during amlodipine treatment in hypertensive patients. Eur J Clin Pharmacol (1994) 0.75
Influence of baseline values. I: Effects on plasma total cholesterol and triglyceride levels during doxazosin treatment for hypertension. Int J Clin Pharmacol Res (1998) 0.75
Reasons for non-compliance with antihypertensive medication in southwest Nigeria. Trop Doct (2004) 0.75
The effects of doxazosin on plasma lipid and lipoprotein levels in hypertensive patients. Pharmacol Res (1995) 0.75
The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications. Afr J Med Med Sci (2001) 0.75
Profuse haematuria in sickle-cell trait. (With a note on renal papillary necrosis). West Afr Med J (1966) 0.75
Biochemical changes during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients. J Pak Med Assoc (1996) 0.75
Artemether in moderately severe and cerebral malaria in Nigerian children. Trans R Soc Trop Med Hyg (1994) 0.75
Effects of amlodipine on plasma lipid and lipoprotein levels in hypertensive patients. J Intern Med (1992) 0.75
Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians. Afr J Med Med Sci (1990) 0.75
Effects of moduretic on plasma lipid and lipoprotein levels in hypertensive African patients. Tokai J Exp Clin Med (1993) 0.75
Quinolones for short-term treatment of uncomplicated urinary tract infection. East Afr Med J (1999) 0.75
Severe falciparum malaria: survival with oral therapy. Trop Geogr Med (1992) 0.75